BioNexus Gene Lab Corp (BGLC)
0.2469
0.00 (0.00%)
USD |
NASDAQ |
Dec 26, 16:00
0.255
+0.01
(+3.28%)
After-Hours: 20:00
BioNexus Gene Lab Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Balchem Corp | 0.1928 |
| Friedman Industries Inc | 0.2785 |
| Innospec Inc | 0.00 |
| Solitario Resources Corp | -- |
| Paramount Gold Nevada Corp | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 11.00M |
| Total Liabilities (Quarterly) | 1.607M |
| Shareholders Equity (Quarterly) | 9.388M |
| Current Ratio | 4.975 |